Global veterinary reach AB7 Group manufactures veterinary products for international laboratories and has a presence in more than 40 countries, signaling a broad distribution network and potential for multinational partnerships or co-branding opportunities.

Active polymers focus Technical emphasis on active polymer technology, self-actives releasing devices, biotechnologies, and natural products suggests potential for collaboration in specialty formulations, controlled-release solutions, and innovative product platforms for pet care, cosmetics, or household segments.

US manufacturing footprint An EPA-certified industrial site in the United States (AB7 America) since 2011 indicates compliance readiness, potential for U.S. market entry strategies, supply chain resilience, and opportunities for onshore manufacturing or co-manufacturing.

GMP certified and legacy GMP certification at the French site and nearly five decades of family-led operations imply strong quality systems, reliability, and long-term partnership potential with distributors, retailers, or multinational brands seeking proven manufacturers.

Sustainable innovation Commitment to responsibility, customer-focused innovation, and a strategy to 'invent the future' align with opportunities to pitch sustainability-aligned product development, reformulation projects, and certifications that appeal to eco-conscious markets.